HVTN 805/HPTN 093

Antiretroviral analytical treatment interruption (ATI) to assess immunologic and virologic responses in participants who initiated ART in early HIV infection after having received VRC01 or placebo in HVTN 703/HPTN 081

Study Summary

Protocol Status: In Development

Study Documents

HVTN 085/HPTN 092 Version 1.0